Rose Geoffrey Beran (CIK 1804146) reported 27 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Sell LUNG (1,778 shares), Sell LUNG (1,557 shares), Sell LUNG (2,434 shares), Sell LUNG (2,254 shares), Sell LUNG (835 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 1,778 | $2,738 |
| 2026-06-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 1,557 | $2,398 |
| 2026-06-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 2,434 | $3,748 |
| 2026-06-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 2,254 | $3,471 |
| 2026-03-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 835 | $1,194 |
| 2026-03-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 2,125 | $3,039 |
| 2026-03-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 1,861 | $2,661 |
| 2026-03-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 2,911 | $4,163 |
| 2026-03-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Buy | 100,000 | $0 |
| 2025-12-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 2,379 | $3,735 |
| 2025-12-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 1,738 | $2,729 |
| 2025-12-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 1,522 | $2,390 |
| 2025-12-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 683 | $1,072 |
| 2025-09-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 707 | $1,131 |
| 2025-09-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 1,799 | $2,878 |
| 2025-09-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 1,575 | $2,520 |
| 2025-09-03 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 2,462 | $3,939 |
| 2025-06-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 401 | $1,259 |
| 2025-06-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 708 | $2,216 |
| 2025-06-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 1,799 | $5,631 |
| 2025-06-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 1,576 | $4,933 |
| 2025-06-04 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 2,463 | $7,709 |
| 2025-03-05 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 520 | $3,702 |
| 2025-03-05 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 915 | $6,515 |
| 2025-03-05 | Pulmonx Corp (LUNG) | CHIEF COMMERCIAL OFFICER | Sell | 2,327 | $16,615 |
Source: SEC Form 4 filings · as of 2026-06-03